| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/07/2006 | US7009034 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eyeast partially disposed within the interior. |
| 03/07/2006 | US7008925 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as immunomodulators and to affect motivation, learning, memory, behaviour, inflammation, body temperature, pain, perception |
| 03/07/2006 | US7008924 heterologous amino acid sequence is fused to another amino acid sequence wherein the heterologous amino acid sequence is a peptide that:aids in detection, isolation, oligomerization, stability of the fusion polypeptide; treating eating disorders |
| 03/07/2006 | US7008922 Transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis. However, the origin and function of H-Y |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008784 prepared from recombinant expression vector comprising heterologous promoter connected to DNA molecule comprising modified HIV genome devoid of long terminal repeat regulatory regions but containing gag ang pol genes in genomic arrangement |
| 03/07/2006 | US7008781 Method of enhancing the biological activity of ligands |
| 03/07/2006 | US7008780 Chimeric DNA-binding proteins |
| 03/07/2006 | US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers |
| 03/07/2006 | US7008774 Immunoassay for detecting exposure to leishmania parasites |
| 03/07/2006 | US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer |
| 03/07/2006 | US7008764 Optimization of cells for endogenous gene activation |
| 03/07/2006 | US7008651 E. coli extract for protein synthesis |
| 03/07/2006 | US7008625 Recombinant constructs of Borrelia burgdorferi |
| 03/07/2006 | US7008624 IL-15 or muteins covalently bound to group (PEG, PVP,PVA, dextran, gelatin) that sterically interferes with signal transduction through IL-15 receptor complex; allograft rejection and graft-versus-host disease |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/07/2006 | CA2220048C Acellular pertussis vaccines and methods of preparation thereof |
| 03/02/2006 | WO2006024041A2 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 03/02/2006 | WO2006024020A2 Hcv non-structural protein mutants and uses thereof |
| 03/02/2006 | WO2006023367A1 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | WO2006023358A1 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | WO2006023356A2 Selective vpac2 receptor peptide agonists |
| 03/02/2006 | WO2006023248A2 Processes for producing and crystallizing g-protein coupled receptors |
| 03/02/2006 | WO2006023226A2 Thymic stromal lymphopoietin promoter and uses therefor |
| 03/02/2006 | WO2006022343A1 Gonadotropic hormone originating in invertebrate and method of producing the same |
| 03/02/2006 | WO2006022215A1 RECOMBINANT VACCINICA VIRUS DIs STRAIN HOLDING DNA ENCODING SARS-CORONAVIRUS PROTEIN AND UTILIZATION THEREOF |
| 03/02/2006 | WO2006021942A2 Platelet modulating oligopeptides |
| 03/02/2006 | WO2006021874A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/02/2006 | WO2006021843A1 A process for producing iron succinyl casein and acetyl-aspartate iron casein complexes and use thereof in pharmaceutical mixtures |
| 03/02/2006 | WO2006021800A2 Tumour model |
| 03/02/2006 | WO2006021599A1 Use of amphiregulin as a protective agent in acute hepatic injury |
| 03/02/2006 | WO2006021453A2 Optimized nucleotide sequences encoding sgp 130 |
| 03/02/2006 | WO2006021451A2 Methods and compounds for treating diabetes |
| 03/02/2006 | WO2006021346A1 Diagnostics and therapeutics for diseases associated with alpha 2b-adrenoceptor (adra2b) |
| 03/02/2006 | WO2006021345A2 Diagnostics and therapeutics for diseases associated with adrenergic alpha-1b receptor (adra1b) |
| 03/02/2006 | WO2006021344A1 Diagnostics and therapeutics for diseases associated with alpha-1a adrenergic receptor (adra1a) |
| 03/02/2006 | WO2006021210A2 Binding member towards pneumolysin |
| 03/02/2006 | WO2006021062A1 Process for obtaining recombinant prothrombin activating protease (rlopap) in monomeric form; the recombinant prothrombin activating protease (rlopap) as well as its amino acid sequence; the use of this protease as a defibrinogenase agent and the diagnosis kit for dysprothrombinemias. |
| 03/02/2006 | WO2006001499A3 Metastin derivatives and use thereof |
| 03/02/2006 | WO2006000740A3 Assay and kits therefor |
| 03/02/2006 | WO2006000448A3 Fc-INTERFERON-BETA FUSION PROTEINS |
| 03/02/2006 | WO2005121172A3 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 03/02/2006 | WO2005118886A3 Stable peptide mimetic of hiv gp41 fusion intermediate |
| 03/02/2006 | WO2005116051A3 Tumor-associated peptides that bind to mhc-molecules |
| 03/02/2006 | WO2005113590A3 Bmp10 propeptides and related methods |
| 03/02/2006 | WO2005110492A3 Method of using adenoviral vectors to induce an immune response |
| 03/02/2006 | WO2005105136A9 Nanogene therapy for cell proliferation disorders |
| 03/02/2006 | WO2005103073A3 Td antigens |
| 03/02/2006 | WO2005100990A3 Diagnostics and therapeutics for diseases associated with purinoceptor 2 type y (p2y2) |
| 03/02/2006 | WO2005095627A3 Method for producing purine nucleosides and nucleotides by fermentation using bacterium belonging to the genus bacillus or escherichia |
| 03/02/2006 | WO2005092114A3 Compositions and methods for destruction of prion infectious proteins |
| 03/02/2006 | WO2005089093A3 Improved expression systems with sec-system secretion |
| 03/02/2006 | WO2005087802A3 Process for producing polypeptides |
| 03/02/2006 | WO2005085286A3 Peptides with antiangiogenic and antitumor activities |
| 03/02/2006 | WO2005077072A3 Hybrid polypeptides with selectable properties |
| 03/02/2006 | WO2005072388A3 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 03/02/2006 | WO2005070827A3 Fullerene based amino acids |
| 03/02/2006 | WO2005070214A3 Peptides for inhibiting insects |
| 03/02/2006 | WO2005069187A3 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 03/02/2006 | WO2005069009A3 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN STEROID PROGESTIN RECEPTOR BETA (mSR-BETA) |
| 03/02/2006 | WO2005059093A3 P ef-tu expression units |
| 03/02/2006 | WO2005058950A3 Methods for generating immunity to antigen |
| 03/02/2006 | WO2005044845A3 Protein binding miniature proteins |
| 03/02/2006 | WO2005037210A3 Photocleavable isotope-coded affinity tags |
| 03/02/2006 | WO2005035569A3 Kiaa0779, splice variants thereof, and methods of their use |
| 03/02/2006 | WO2005032487A3 Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus |
| 03/02/2006 | WO2005012527A9 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 03/02/2006 | WO2004094465A3 Synthetic molecules that mimic chemokines |
| 03/02/2006 | WO2004092332A3 Sars virus polypeptides |
| 03/02/2006 | WO2004083447A3 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 03/02/2006 | WO2004066933A3 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 03/02/2006 | WO2004061086A3 Flj10607 as modifier of the axin pathway and methods of use |
| 03/02/2006 | WO2004057940A3 Canine dioxin/aryl hydrocarbon receptor sequences |
| 03/02/2006 | WO2004050672A3 Process for the extraction and isolation of insulin from recombinant sources |
| 03/02/2006 | WO2004046331A3 2’-branched nucleosides and flaviviridae mutation |
| 03/02/2006 | WO2004039334A3 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING |
| 03/02/2006 | WO2004029631A3 Method for identifying bhs-specific proteins and fragments thereof |
| 03/02/2006 | WO2004020583A3 Polynucleotide predictor set for identifying protein tyrosine kinase modulators |
| 03/02/2006 | WO2004009772A3 Npc1l1 (npc3) and methods of use thereof |
| 03/02/2006 | WO2004007528A3 Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange |
| 03/02/2006 | WO2003077875A3 Proteins associated with growth, differentiation, and death |
| 03/02/2006 | WO2003070879A3 Cyclin dependent kinase 5 phosphorylation of disabled 1 protein |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | WO2002090925A3 Polypeptides and nucleic acids associated with cancer |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | US20060048245 Methods for improving seeds |
| 03/02/2006 | US20060048239 Plants having modified growth characteristics and a method for making the same |
| 03/02/2006 | US20060048238 Transgenic tieg non-human animals |
| 03/02/2006 | US20060047107 Cortistatin: neuropeptides, compositions and methods |
| 03/02/2006 | US20060047106 Neisseria meningitdis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof |
| 03/02/2006 | US20060046959 Novel leptin antagonist |
| 03/02/2006 | US20060046295 Helper virus-free AAV production |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/02/2006 | US20060046250 Novel use of aim 3 acting as a tumor suppressor |
| 03/02/2006 | US20060046249 Identification of polynucleotides and polypetide for predicting activity of compounds that interact with protein tyrosine kinase and or protein tyrosine kinase pathways |
| 03/02/2006 | US20060046248 RNA interference in avians |
| 03/02/2006 | US20060045888 Antigen library immunization |
| 03/02/2006 | US20060045878 Pancreas-derived plasminogen activator inhibitor |
| 03/02/2006 | US20060045876 Fusion proteins of humanized g250 specific antibodies and uses thereof |
| 03/02/2006 | US20060045875 Method of use of crotoxin as an anti-retroviral agent |